LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.74 USD Market Closed
Market Cap: 45.8m USD

LAVA Therapeutics NV
Selling, General & Administrative

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

LAVA Therapeutics NV
Selling, General & Administrative Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
LAVA Therapeutics NV
NASDAQ:LVTX
Selling, General & Administrative
-$13.2m
CAGR 3-Years
-3%
CAGR 5-Years
-61%
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Selling, General & Administrative
-$204m
CAGR 3-Years
-4%
CAGR 5-Years
-26%
CAGR 10-Years
-44%
ProQR Therapeutics NV
NASDAQ:PRQR
Selling, General & Administrative
-€15.1m
CAGR 3-Years
10%
CAGR 5-Years
-1%
CAGR 10-Years
-8%
Uniqure NV
NASDAQ:QURE
Selling, General & Administrative
-$55m
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
-11%
argenx SE
XBRU:ARGX
Selling, General & Administrative
-$1.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Selling, General & Administrative
-$99.3m
CAGR 3-Years
-28%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
No Stocks Found

LAVA Therapeutics NV
Glance View

Market Cap
45.8m USD
Industry
Biotechnology

LAVA Therapeutics NV operates as a biotechnology company, which develops immune oncology biopharmaceutical products. The company is headquartered in Utrecht, Utrecht and currently employs 55 full-time employees. The firm focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.

LVTX Intrinsic Value
2.52 USD
Undervaluation 31%
Intrinsic Value
Price

See Also

What is LAVA Therapeutics NV's Selling, General & Administrative?
Selling, General & Administrative
-13.2m USD

Based on the financial report for Dec 31, 2024, LAVA Therapeutics NV's Selling, General & Administrative amounts to -13.2m USD.

What is LAVA Therapeutics NV's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-61%

Over the last year, the Selling, General & Administrative growth was 6%. The average annual Selling, General & Administrative growth rates for LAVA Therapeutics NV have been -3% over the past three years , -61% over the past five years .

Back to Top